Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Patients and data tracking

Biogen Idec building

ICER says price of Biogen’s Aduhelm should be much lower

US cost-effectiveness watchdog’s analysis estimates current annual list price of $56,000 could be reduced to $3,000 to $8,400

- PMLiVE

WHITE PAPER: From bench to bedside in one year – how the race for a COVID-19 vaccine will change the future of drug development

In this edition of MAGNIFI, we discuss the factors behind this acceleration in development of the COVID-19 vaccines and what this might mean for the future of pharma

IGNIFI

- PMLiVE

Final data shows CureVac’s COVID-19 vaccine is only 48% effective

New data shows slight improvement over previously reported 47% overall efficacy in interim analysis

Video

Virtual Conference Live

Inizio

Report

Digital Health Tools - Physician Trends

Inizio

Webcast

Oncology landscape: How innovative market research methods can navigate you to success

Inizio

- PMLiVE

Oxford PharmaGenesis named in Medical Marketing and Media’s Agency 100 report

Media brand Medical Marketing and Media (MM+M) has listed Oxford PharmaGenesis in the latest Agency 100 – the annual definitive ‘who’s who’ ranking of the sector’s top healthcare marketing firms...

- PMLiVE

How can compelling healthcare communications support HCPs with their pandemic patient backlog?

Read our latest article, written by Chris Barton (Strategic Solutions Director), who shares his thoughts on how pharmaceutical companies and medical communication companies, like Bedrock, can support healthcare systems to...

Bedrock Healthcare Communications

- PMLiVE

Pharma marketers’ blog: How to get your tactical mix right in the new normal

Optimising your promotional effectiveness and ultimate customer experiences

MSL Digital Offices and HCP Community Boards: A Customer Story

Learn how our client is leveraging the Impetus InSite Platform® to host company-wide “digital offices” and community boards for MSLs and HCPs to connect one-on-one or one-to-many.

Impetus Digital

- PMLiVE

MHRA grants bluebird bio’s LentiGlobin gene therapy an ‘innovation passport’

The Innovative Licensing and Access Pathway scheme aims to help speed approval of innovative treatments

- PMLiVE

Moderna says its COVID-19 vaccine appears effective against Delta and other variants

Earlier this year, the company revealed early evidence that its booster jabs may be effective against ‘variants of concern’

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links